Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte
- 28 December 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 364 (4), 1002-1008
- https://doi.org/10.1016/j.bbrc.2007.10.125
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Ginsenosides compound K and Rh2 inhibit tumor necrosis factor-α-induced activation of the NF-κB and JNK pathways in human astroglial cellsNeuroscience Letters, 2007
- Polyphenols Stimulate AMP-Activated Protein Kinase, Lower Lipids, and Inhibit Accelerated Atherosclerosis in Diabetic LDL Receptor–Deficient MiceDiabetes, 2006
- Environmental Obesogens: Organotins and Endocrine Disruption via Nuclear Receptor SignalingEndocrinology, 2006
- Caspase-3-dependent protein kinase C delta activity is required for the progression of Ginsenoside-Rh2-induced apoptosis in SK-HEP-1 cellsCancer Letters, 2005
- Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cellsCancer Chemotherapy and Pharmacology, 2005
- The AMP-activated protein kinase cascade – a unifying system for energy controlTrends in Biochemical Sciences, 2004
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- AMP-activated Protein Kinase Activity Is Critical for Hypoxia-inducible Factor-1 Transcriptional Activity and Its Target Gene Expression under Hypoxic Conditions in DU145 CellsOnline Journal of Public Health Informatics, 2003
- The Anti-diabetic Drugs Rosiglitazone and Metformin Stimulate AMP-activated Protein Kinase through Distinct Signaling PathwaysOnline Journal of Public Health Informatics, 2002
- Ginseng pharmacology: Multiple constituents and multiple actionsBiochemical Pharmacology, 1999